Nymox Pharmaceutical Market Cap

Nymox Pharmaceutical has a market cap or net worth of $4.85 million as of April 29, 2026. Its market cap has decreased by -48.73% in one year.

Market Cap

4.85M

Enterprise Value

8.06M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.06

Market Cap Chart

Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 4.85M, a decrease of -95.89%. That is a compound annual growth rate of -10.62%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	4.85M	18.16%
Dec 31, 2025	4.10M	-56.61%
Dec 31, 2024	9.45M	-82.82%
Dec 29, 2023	55.03M	86.49%
Dec 30, 2022	29.51M	-73.23%
Dec 31, 2021	110.23M	-42.54%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AccuStem Sciences	4.50M
Mosaic ImmunoEngineering	5.40M
Institute of Biomedical Research	5.50M
GPL Holdings	4.17M
Bioxytran	3.85M
TRON Group	6.27M
Curative Biotechnology	6.70M
Orgenesis	7.06M

Market Cap Rankings